Addressing disparities in sudden cardiac arrest care and the underutilization of effective therapies
- PMID: 20934553
- PMCID: PMC2956019
- DOI: 10.1016/j.ahj.2010.07.011
Addressing disparities in sudden cardiac arrest care and the underutilization of effective therapies
Abstract
Sudden cardiac arrest (SCA) is the most common cause of death in the Unites States. Despite its major impact on public health, significant challenges exist at the patient, provider, public, and policy levels with respect to raising more widespread awareness and understanding of SCA risks, identifying patients at risk for SCA, addressing barriers to SCA care, and eliminating disparities in SCA care and outcomes. To address many of these challenges, the Duke Center for the Prevention of Sudden Cardiac Death at the Duke Clinical Research Institute (Durham, NC) held a think tank meeting on December 7, 2009, convening experts on this issue from clinical cardiology, cardiac electrophysiology, health policy and economics, the US Food and Drug Administration, the Centers for Medicare and Medicaid Services, the Agency for Health Care Research and Quality, and device and pharmaceutical manufacturers. The specific goals of the meeting were to examine existing educational tools on SCA for patients, health care providers, and the public and explore ways to enhance and disseminate these tools; to propose a framework for improved identification of patients at risk of SCA; and to review the latest data on disparities in SCA care and explore ways to reduce these disparities. This article summarizes the discussions that occurred at the meeting.
Copyright © 2010 Mosby, Inc. All rights reserved.
Figures
Similar articles
-
Quality of care for sudden cardiac arrest: Proposed steps to improve the translation of evidence into practice.Am Heart J. 2011 Aug;162(2):222-31. doi: 10.1016/j.ahj.2011.04.021. Epub 2011 Jul 7. Am Heart J. 2011. PMID: 21835281 Review.
-
Preventing tomorrow's sudden cardiac death today: dissemination of effective therapies for sudden cardiac death prevention.Am Heart J. 2008 Oct;156(4):613-22. doi: 10.1016/j.ahj.2008.05.027. Epub 2008 Jul 26. Am Heart J. 2008. PMID: 18926144
-
Performance measures to promote quality improvement in sudden cardiac arrest prevention and treatment.Am Heart J. 2013 Jun;165(6):862-8. doi: 10.1016/j.ahj.2013.02.010. Epub 2013 Apr 6. Am Heart J. 2013. PMID: 23708156 Review.
-
Preventing tomorrow's sudden cardiac death today: part I: Current data on risk stratification for sudden cardiac death.Am Heart J. 2007 Jun;153(6):941-50. doi: 10.1016/j.ahj.2007.03.003. Am Heart J. 2007. PMID: 17540194
-
Preventing tomorrow's sudden cardiac death today: part II: Translating sudden cardiac death risk assessment strategies into practice and policy.Am Heart J. 2007 Jun;153(6):951-9. doi: 10.1016/j.ahj.2007.03.002. Am Heart J. 2007. PMID: 17540195
Cited by
-
Efficacy and safety of implantable cardioverter-defibrillator implantation in the elderly-The I-70 Study: A randomized clinical trial.Heart Rhythm O2. 2024 Apr 27;5(6):365-373. doi: 10.1016/j.hroo.2024.04.010. eCollection 2024 Jun. Heart Rhythm O2. 2024. PMID: 38984364 Free PMC article.
-
Association of race and in-hospital outcomes following acute pulmonary embolism: A retrospective cohort study.Clin Cardiol. 2023 Jul;46(7):768-776. doi: 10.1002/clc.24055. Epub 2023 May 31. Clin Cardiol. 2023. PMID: 37255216 Free PMC article.
-
Do acute changes in ambient air pollution increase the risk of potentially fatal cardiac arrhythmias in patients with implantable cardioverter defibrillators?Environ Health. 2020 Jun 18;19(1):72. doi: 10.1186/s12940-020-00622-w. Environ Health. 2020. PMID: 32552837 Free PMC article.
-
Association of Racial Bias With Burnout Among Resident Physicians.JAMA Netw Open. 2019 Jul 3;2(7):e197457. doi: 10.1001/jamanetworkopen.2019.7457. JAMA Netw Open. 2019. PMID: 31348503 Free PMC article.
-
Medical facilities in the neighborhood and incidence of sudden cardiac arrest.Resuscitation. 2018 Sep;130:118-123. doi: 10.1016/j.resuscitation.2018.07.005. Epub 2018 Jul 6. Resuscitation. 2018. PMID: 30057353 Free PMC article.
References
-
- The Cardiac Insufficiency Bisoprolol Study II (CIBIS-II): a randomised trial. Lancet. 1999;353:9–13. - PubMed
-
- Hjalmarson A, Goldstein S, Fagerberg B, et al. Effects of controlled-release metoprolol on total mortality, hospitalizations, and well-being in patients with heart failure: the Metoprolol CR/XL Randomized Intervention Trial in congestive heart failure (MERIT-HF). MERIT-HF Study Group. JAMA. 2000;283:1295–1302. - PubMed
-
- Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure. The SOLVD Investigators. N Engl J Med. 1991;325:293–302. - PubMed
-
- Effects of enalapril on mortality in severe congestive heart failure. Results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS). The CONSENSUS Trial Study Group. N Engl J Med. 1987;316:1429–1435. - PubMed
-
- Pitt B, Remme W, Zannad F, et al. Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction. N Engl J Med. 2003;348:1309–1321. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
